Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Endocrinology

Treatment Options: From Monitoring to Surgery

At a Glance

Multinodular goiter treatment depends on thyroid hormone activity, symptoms, nodule findings, goiter size, and personal goals. Options include monitoring, radioactive iodine, radiofrequency ablation for selected benign nodules, or surgery for compression or cancer concern.

Choosing a treatment for multinodular goiter (MNG) is not a one-size-fits-all process. The “best” treatment depends on whether your thyroid is overactive, if it is pressing on your neck structures, whether there are cosmetic concerns, and your personal health goals [1][2]. Even without severe breathing symptoms, treatment may be reasonable for progressive growth or bothersome neck fullness.

Medical Management for Toxic Goiters

If you have a toxic goiter causing hyperthyroidism, your doctor may prescribe medications to control the symptoms before moving to a definitive treatment like RAI or surgery:

  • Beta-blockers: These help control the racing heart, tremors, and anxiety caused by excess hormone.
  • Antithyroid medications (e.g., methimazole): These lower the amount of hormone your thyroid produces. While they stabilize your hormone levels, they generally do not eliminate the autonomous nodules causing the problem.

Active Surveillance: The “Watch and Wait” Approach

If your goiter is nontoxic, asymptomatic, and your biopsies are benign, you may not need active treatment [2].

  • What it involves: Regular clinical exams and ultrasounds to ensure the nodules aren’t growing rapidly or developing suspicious features [3].

Radioactive Iodine (RAI) Therapy

RAI is a common treatment for toxic goiters and is sometimes used for large nontoxic goiters in people who cannot have or decline surgery [4][5].

  • How it works: You swallow a pill or liquid containing radioactive iodine. Because thyroid tissue (along with the salivary glands, stomach, and lactating breast tissue) concentrates iodine preferentially, the radiation targets the thyroid and slowly shrinks the nodules [6][7].
  • Important Safety Notes: RAI is never used during pregnancy or breastfeeding. You must discuss the timing of pregnancy planning and breastfeeding cessation with a specialist. Also, recent IV contrast (which contains iodine) can interfere with RAI treatment. You will be given specific radiation safety precautions to follow for a few days after treatment.
  • Results and Limitations: It can reduce goiter size by about 30% to 40%, but the shrinkage is slow (taking months) [5]. It is not suitable if you have urgent airway compression. Many people eventually develop hypothyroidism and will need lifelong hormone replacement [8][9].

Radiofrequency Ablation (RFA): A Non-Surgical Alternative

RFA is a minimally invasive option for carefully selected patients with benign nodules that cause cosmetic or compressive symptoms [10][11].

  • The Procedure: Under ultrasound guidance, a doctor inserts a thin probe into the nodule. The tip releases controlled heat to destroy the nodule tissue from the inside [12].
  • Selection: The target nodule must have been rigorously confirmed as benign (often requiring two benign FNA results). It is not a substitute for evaluating indeterminate or suspicious nodules [13].
  • Benefits and Limitations: It is done under local anesthesia and leaves no scar. However, it treats specific nodules, not the whole multinodular gland. Large or multiple nodules may require staged, repeat treatments. Risks, while uncommon, include bleeding, skin injury, and voice-nerve injury [14][15].

Surgical Options

Surgery is recommended for high suspicion of cancer, severe compressive symptoms, very large substernal goiters, or patient preference [16][17].

1. Thyroid Lobectomy (Hemithyroidectomy)

The surgeon removes only one side of the thyroid [18].

  • Pros: Lower risk of permanent damage to the parathyroid glands (calcium control) and the recurrent laryngeal nerve. There is a chance the remaining lobe will produce enough hormone, though hypothyroidism can still occur [19][18].
  • Cons: There is roughly a 30% rate of nodule growth in the remaining lobe over many years. This means regrowth is possible, though it does not automatically mean a second operation will be necessary [19][20].

2. Total Thyroidectomy

The surgeon removes the entire thyroid gland [21].

  • Pros: It provides the most definitive treatment, heavily reducing the chance of goiter recurrence (though small recurrences from residual tissue are rarely possible) [22].
  • Cons: You will definitely need lifelong daily thyroid hormone replacement [18].

Surgical Risks

All thyroid surgeries carry general risks like infection and anesthesia complications. Specific risks include:

  1. Recurrent Laryngeal Nerve Injury: This nerve controls your voice. Injury can cause temporary or permanent hoarseness [21][18].
  2. Hypocalcemia/Hypoparathyroidism: Damage to the parathyroid glands can cause low calcium. This is often temporary but can be permanent, requiring lifelong calcium supplements [21].
  3. Neck Hematoma: Postoperative bleeding in the neck is rare but is an airway emergency that requires immediate medical intervention [18].

Common questions in this guide

When is watchful monitoring reasonable for a multinodular goiter?
Monitoring may be reasonable when a goiter is not producing excess thyroid hormone, causes no symptoms, and biopsies are benign. Follow-up usually includes clinical examinations and ultrasound. Rapid growth, new suspicious ultrasound features, or worsening pressure or swallowing symptoms may lead to active treatment.
How much can radioactive iodine shrink a multinodular goiter?
Radioactive iodine is swallowed as a pill or liquid and is concentrated by thyroid tissue, gradually shrinking the nodules. It can reduce goiter size by about 30% to 40%, usually over months, so it is not appropriate for urgent airway compression. It is not used during pregnancy or breastfeeding, and many people later need thyroid hormone replacement.
Can radiofrequency ablation replace surgery for multinodular goiter?
Radiofrequency ablation can be an option for selected patients whose nodules have been rigorously confirmed benign and cause cosmetic or compressive symptoms. It uses ultrasound guidance and local anesthesia, but it treats individual nodules rather than the entire gland, so large or multiple nodules may need staged or repeat procedures. It should not be used instead of evaluating an indeterminate or suspicious nodule.
When is thyroid surgery recommended for multinodular goiter?
Surgery may be recommended when cancer is strongly suspected, the goiter causes severe compression, a large portion extends behind the breastbone, or the patient prefers definitive treatment. A lobectomy removes one side and may preserve some thyroid function, while total thyroidectomy removes the gland and requires lifelong thyroid hormone replacement. The best operation depends on the nodules, symptoms, anatomy, and goals.
What are the main risks of multinodular goiter surgery?
Important risks include temporary or permanent voice changes from injury to the recurrent laryngeal nerve, low calcium from parathyroid injury, infection, and anesthesia complications. A neck hematoma is rare but can threaten the airway and requires immediate medical attention. Ask the surgeon about their rates of permanent voice-nerve injury and permanent hypoparathyroidism.
What happens after a thyroid lobectomy for multinodular goiter?
After a lobectomy, the remaining thyroid lobe may produce enough hormone, but some people still develop hypothyroidism and need replacement hormone. Nodules in the remaining lobe can grow over many years, but regrowth does not automatically mean a second operation is needed. Follow-up thyroid tests and imaging help guide care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that I have nodules on both sides, what is the risk of me needing a second surgery later if we only perform a lobectomy now?
  2. 2.How many radiofrequency ablation (RFA) procedures have you performed for multinodular goiter, and what is your specific success rate for nodule shrinkage?
  3. 3.If we choose radioactive iodine, how much volume reduction can we realistically expect for a goiter of my size?
  4. 4.What are your personal rates for permanent vocal cord paralysis and permanent hypoparathyroidism for the type of surgery you are recommending?
  5. 5.If I choose active surveillance, what specific changes in my ultrasound or symptoms would trigger a move toward active treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters.

    Knobel M

    Journal of endocrinological investigation 2016; (39(4)):357-73 doi:10.1007/s40618-015-0391-7.

    PMID: 26392367
  2. 2

    Non-Toxic Multinodular Goiter: From Etiopathogenesis to Treatment.

    Unlu MT, Kostek M, Aygun N, et al.

    Sisli Etfal Hastanesi tip bulteni 2022; (56(1)):21-40 doi:10.14744/SEMB.2022.56514.

    PMID: 35515961
  3. 3

    AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

    Gharib H, Papini E, Garber JR, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2016; (22(5)):622-39 doi:10.4158/EP161208.GL.

    PMID: 27167915
  4. 4

    2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

    Ross DS, Burch HB, Cooper DS, et al.

    Thyroid : official journal of the American Thyroid Association 2016; (26(10)):1343-1421 doi:10.1089/thy.2016.0229.

    PMID: 27521067
  5. 5

    Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.

    Riguetto CM, Miguel VP, Pavin EJ, et al.

    Nuclear medicine communications 2020; (41(8)):727-732 doi:10.1097/MNM.0000000000001213.

    PMID: 32427701
  6. 6

    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism.

    Mariani G, Tonacchera M, Grosso M, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(3)):304-312 doi:10.2967/jnumed.120.243170.

    PMID: 33008929
  7. 7

    Does Radioactive Iodine Treatment Affect Thyroid Size and Tracheal Diameter?

    Yazici Demir K, Kaya Z, Dayanan R, et al.

    Journal of clinical medicine 2024; (14(1)) doi:10.3390/jcm14010115.

    PMID: 39797198
  8. 8

    Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine.

    Moroto D, Torquato-Vieira ICO, Fiorin LB, et al.

    Clinical nuclear medicine 2024; (49(6)):529-535 doi:10.1097/RLU.0000000000005189.

    PMID: 38619976
  9. 9

    Long-term effects of radioiodine treatment on thyroid functions and ultrasonographic features in patients with toxic adenoma and toxic multinodular goitre.

    Koç I, Bahçecioğlu AB, Avcı Merdin F, et al.

    Annals of nuclear medicine 2023; (37(6)):371-379 doi:10.1007/s12149-023-01834-z.

    PMID: 37010726
  10. 10

    2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules.

    Papini E, Monpeyssen H, Frasoldati A, Hegedüs L

    European thyroid journal 2020; (9(4)):172-185 doi:10.1159/000508484.

    PMID: 32903999
  11. 11

    Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group.

    Papini E, Pacella CM, Solbiati LA, et al.

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2019; (36(1)):376-382 doi:10.1080/02656736.2019.1575482.

    PMID: 30909759
  12. 12

    Radiofrequency ablation of benign thyroid nodules: A prospective, multi-institutional North American experience.

    Russell JO, Desai DD, Noel JE, et al.

    Surgery 2024; (175(1)):139-145 doi:10.1016/j.surg.2023.07.046.

    PMID: 37953141
  13. 13

    Laser, radiofrequency, and ethanol ablation for the management of thyroid nodules.

    Papini E, Gugliemi R, Pacella CM

    Current opinion in endocrinology, diabetes, and obesity 2016; (23(5)):400-6 doi:10.1097/MED.0000000000000282.

    PMID: 27504993
  14. 14

    Propensity-matched analysis of treatment outcomes of thermal ablation versus surgery for multinodular goiters.

    Guo R, Guo X, Wu T, et al.

    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2025; (42(1)):2579243 doi:10.1080/02656736.2025.2579243.

    PMID: 41381370
  15. 15

    Radiofrequency Ablation for the Treatment of Benign Thyroid Nodules: 10-Year Experience.

    Park SI, Baek JH, Lee DH, et al.

    Thyroid : official journal of the American Thyroid Association 2024; (34(8)):990-998 doi:10.1089/thy.2024.0082.

    PMID: 39041607
  16. 16

    Substernal Goiter: From Definitions to Treatment.

    Unlu MT, Aygun N, Kostek M, et al.

    Sisli Etfal Hastanesi tip bulteni 2022; (56(2)):167-176 doi:10.14744/SEMB.2022.30806.

    PMID: 35990303
  17. 17

    Current approach to surgical management of hyperthyroidism.

    Barczyński M

    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2021; (65(2)):124-131 doi:10.23736/S1824-4785.21.03330-6.

    PMID: 33494587
  18. 18

    Does hemithyroidectomy still provide any benefit?

    Sarfati-Lebreton M, Toqué L, Philippe JB, et al.

    Annales d'endocrinologie 2019; (80(2)):101-109 doi:10.1016/j.ando.2018.09.006.

    PMID: 30583800
  19. 19

    Is hemithyroidectomy a rational management for benign nodular goitre? A Multicentre Retrospective Single Group Study.

    Attaallah W, Erel S, Canturk NZ, et al.

    The Netherlands journal of medicine 2015; (73(1)):17-22.

    PMID: 26219937
  20. 20

    Unilateral benign multinodular versus solitary goiter: Long-term contralateral reoperation rates after lobectomy.

    de Rienzo-Madero B, Sabra JP, Gand E, et al.

    Surgery 2019; (165(1)):75-79 doi:10.1016/j.surg.2018.04.074.

    PMID: 30415868
  21. 21

    Total vs less than total thyroidectomy for benign multinodular non-toxic goiter: an updated systematic review and meta-analysis.

    Bharath S, Yadav SK, Sharma D, et al.

    Langenbeck's archives of surgery 2023; (408(1)):200 doi:10.1007/s00423-023-02941-1.

    PMID: 37204607
  22. 22

    Bilateral benign multinodular goiter: What is the adequate surgical therapy? A review of literature.

    Mauriello C, Marte G, Canfora A, et al.

    International journal of surgery (London, England) 2016; (28 Suppl 1()):S7-12.

    PMID: 26708850

This page is for informational purposes only and does not constitute medical advice. Your endocrinologist and surgeon can help interpret your thyroid tests and choose the safest option for your symptoms and goals.

Get notified when new evidence is published on multinodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.